Vimarsana
Biggest News Aggregation in the World

Page 3 - Akili Interactive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akili Interactive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akili Interactive Today - Breaking & Trending Today

Virtual Clinical Trials Market Set to Soar Past USD 12.85 - Vimarsana News

Virtual Clinical Trials Market Set to Soar Past USD 12.85

Discover the comprehensive landscape of Virtual Clinical Trials, delving into their size, share, and growth analysis. Explore their applications in...

Emerging Trends and Key Drivers Fuelling the Global Digital Biomarker Market Growth forecast 2025 – Hometown Pages - Vimarsana News

Emerging Trends and Key Drivers Fuelling the Global Digital Biomarker Market Growth forecast 2025 – Hometown Pages

MarkNtel Advisors is dedicated to delivering in-depth & comprehensive market research study. Their reports are known for providing unbiased inform

EndeavorRx: Digital Theraupeutic for Children with ADHD - Vimarsana News

EndeavorRx: Digital Theraupeutic for Children with ADHD

EndeavorRx is a prescription digital therapeutic approved for the treatment of children with ADHD. EndeavorOTC is a video game app designed to treat ADD symptoms in adults.

U.S. Digital Therapeutics Market to Reach $21.46B by 2030 - Vimarsana News

U.S. Digital Therapeutics Market to Reach $21.46B by 2030

The U.S. digital therapeutics market size is estimated to reach $21.46B by 2030, expanding at a CAGR of 33.8% from 2023 to 2030

Qelbree improved symptoms, executive function after 1 year in adults with ADHD - Vimarsana News

Qelbree improved symptoms, executive function after 1 year in adults with ADHD

MIAMI BEACH, Fla. — Administration of Qelbree for up to 1 year showed similar safety, efficacy and tolerability profiles seen in shorter trials with improvement in ADHD symptoms and executive function, according to a study presented here. “The world needs more nonstimulants for ADHD,” Andrew J. Cutler, MD, associate clinical professor in the department of psychiatry, SUNY

Source: healio.com